Clinical Trial Update: Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity

View source ↗

Summary

The registry trial evaluating Avive Soft Tissue Membrane for acute upper-extremity trauma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Extremity Trauma

Drugs mentioned

• Avive Soft Tissue Membrane (human placental membrane (amniotic/chorion membrane) graft)

Snippet

Sponsor: Axogen Corporation | Conditions: Acute Upper Extremity Trauma | Status: TERMINATED